Estimating common parameters of lognormally distributed environmental and biomonitoring data: Harmonizing disparate statistics from publications

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 17, Issue 6, 2014, Pages 341-368

  Pleil, Joachim D ^a   Sobus, Jon R ^a   Stiegel, Matthew A ^b   Hu, Di ^a   Oliver, Karen D ^a   Olenick, Cassandra ^c   Strynar, Mark ^a   Clark, Mary ^d   Madden, Michael C ^e   Funk, William E ^f  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c EMORY UNIVERSITY   (United States)

^d North Carolina Department of Environment and Natural Resources   (United States)

^e U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; BENZENE; BENZO[A]PYRENE; DIMETHYL DISULFIDE; PERFLUORO COMPOUND; TUMOR NECROSIS FACTOR ALPHA; VOLATILE ORGANIC COMPOUND;

AMBIENT AIR; ARITHMETIC; BIOLOGICAL MONITORING; BLOOD ANALYSIS; BREATH ANALYSIS; CONFIDENCE INTERVAL; ENVIRONMENTAL MONITORING; FUNGUS SPORE; GEOMETRIC MEAN; GEOMETRIC STANDARD DEVIATION; NORMAL DISTRIBUTION; PARTICULATE MATTER; PREDICTION; PROBABILITY; REVIEW; STANDARD; STATISTICAL ANALYSIS; STATISTICAL CONCEPTS; ENVIRONMENTAL HEALTH; HUMAN; MEDICAL RESEARCH; METHODOLOGY; PUBLISHING; STANDARDS; STATISTICAL MODEL;

BIOMEDICAL RESEARCH; DATA INTERPRETATION, STATISTICAL; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; HUMANS; MODELS, STATISTICAL; PUBLISHING; RESEARCH DESIGN;

EID: 84921757194     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937404.2014.956854     Document Type: Review

References (109)

1. Agency for Toxic Substances and Disease Registry. 2013. Arsenic. http://www.atsdr.cdc. gov/substances/toxsubstance.asp?toxid=3
2. Ahmadzai, H., Huang, S., Hettiarachchi, R., Lin, J. L., Thomas, P. S., and Zhang, Q. 2013. Exhaled breath condensate: A comprehensive update. Clin. Chem. Lab. Med. 51:1343-1361.
3. Ankley, G. T., Bennett, R. S., Erickson, R. J., Hoff, D. J., Hornung, M. W., Johnson, R. D., Mount, D. R., Nichols, J. W., Russom, C. L., Schmieder, P. K., Serrrano, J. A., Tietge, J. E., and Villeneuve, D. L. 2010. Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 29: 730-741.
4. Annesi-Maesano, I., Baiz, N., Banerjee, S., Rudnai, P., and Rive, S., on behalf of SINPHONIE Group. 2013. Indoor air quality and sources in schools and related health effects. J. Toxicol. Environ. Health B 16: 491-550.
5. Arnold, S. M., Angerer, J., Boogard, P. J., Hughes, M. F., O'Lone, R. B., Robison, S. H., and Schnatter, A. R. 2013. The use of biomonitoring data in exposure and human health risk assessment: Benzene case study. Crit. Rev. Toxicol. 43: 119-153.
6. Arnold, C, 2013. Disease burdens associated with PM2.5 exposure: How a new model provided global estimates. Environ. Health Perspect. 122: A111.
7. Aylward, L. L., Kirman, C. R., Schoeny, R., Portier, C. J., Hays, S. M. 2013. Evaluation of Biomonitoring Data from the CDC National Exposure Report in a Risk Assessment Context: Perspectives across Chemicals. Environ Health Persp 121:287-294.
8. Becker, S., Mundandhara, S., Devlin, R. B., and Madden, M. C. 2005. Regulation of cytokine production in human alveolar macrophages and airway epithelial cells in response to ambient air pollution particles: Further mechanistic studies. Toxicol. Appl. Pharmacol. 207(2 suppl.): 269-275.
9. Berger, A. 2000. Th1 and Th2 responses: What are they? Br. Med. J. 321: 424.
10. Bernstam, L., and Nriagu, J. 2000. Molecular aspects of arsenic stress. J. Toxicol. Environ. Health B 3: 293-322.
11. Bostrom, C. E., Gerde, P, Hanberg, A., Jernstrom, B., Johansson, C., Kyrklund, T., Rannug, A., Tornqvist, M., Victorin, K., and Westerholm, R. 2002. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ. Health Perspect. 110(suppl. 3): 451-488.
12. Brook, R. D., Franklin, B., Cascio, W., Hong, Y., Howard, G., Lipsett, M., Luepker, R., Mittleman, M., Samet, J., Smith, S. C., and Tager, I. 2004. Air pollution and cardiovascular disease: A statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 109: 2655-2671.
13. Celik, I., Gallicchio, L., Boyd, K., Lam, T. K., Matanoski, G., Tao, X., Shiels, M., Hammond, E., Chen, L., Robinson, K. A., Caulfield, L. E., Herman, J. G., Guallar, E., and Alberg, A. J. 2008. Arsenic in drinking water and lung cancer: A systematic review. Environ. Res. 108: 48-55.
14. Chen, H., Goldberg, M. S., and Villeneuve, P. J. 2008. A systematic review of the relation between long-term exposure to ambient air pollution and chronic diseases. Rev. Environ. Health 23: 243-297.
15. Chen, Y., Parvez, F., Gamble, M., Islam, T., Ahmed, A., Argos, M., Graziano, J. H., and Ahsan, H. 2009. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: Review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol. Appl. Pharmacol. 239: 184-192.
16. Chiu, H.-F., Tsai, S.-S., Weng, H.-H., and Yang, C.-Y. 2013. Short-term effects ogfm fine particulate air pollution on emergency room visits for cardiac arrhythmias: A case-crossover study in Taipei. J. Toxicol. Environ. Health A 76: 614-623.
17. Collins, J. F., Brown, J. P., Dawson, S. V., and Marty, M. A. 1991. Risk assessment for benzo[a]pyrene. Regul. Toxicol. Pharmacol. 13:170-184.
18. Collins, J. F., Brown, J. P., Alexeeff, G. V., and Salmon, A. G. 1998. Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul. Toxicol. Pharmacol. 28: 45-54.
19. Conney, A. H., Chang, R. L., Ierina, D. M., and Wei, S. J. C. 1994. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev. 26: 125-163.
20. Cope,K.A.,Watson,M.T.,Foster,W.M.,Sehnert, S. S., and Risby, T. H. 2003. Effects of ventilation on the collection of exhaled breath in humans. J. Appl. Physiol. 96: 1371-1379.
21. Crow, E. L., and Shimizu, K. 1988. Lognormal distributions: Theory and applications. New York, NY: Marcel Dekker.
22. Daughtrey, E. H., Jr., Adams, J. R., Oliver, K.D., Kronmiller, K.G., and McClenny, W.A. 1998. Performance characteristics of an automated gas chromatograph-ion trap mass spectrometer system used for the 1995 Southern Oxidant Study field investigation in Nashville, Tennessee. J. Geophys. Res. Atmos 103: 22375-22386.
23. Dejmek, J., Solansky, I., Benes, I., Lenicek, J., and Sram, R. J. 2000. The impact of polycyclic aromatic hydrocarbons and fine particles on pregnancy outcome. Environ. Health Perspect. 108:1159-1164.
24. De Lacy-Costello, B., Amann, A., Al-Kateb, H., Flynn, C., Filipiak, W., Khalid, T., Osborne, D., and Ratcliffe, N. M. 2014 A review of the volatiles from the healthy human body. J. Breath Res. 8: 014001.
25. Diaz-Villasenor, A., Burns, A. L., Hiriart, M., Cebrian, M. E., and Ostrosky-Wegman, P. 2007. Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus. Toxicol. Appl. Pharmacol. 225: 123-133.
26. Di Francia, M., Barbier, D., Mege, J. L., and Orehek, J. 1994. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 150: 1453-1455.
27. Eduard, W. 2009. Fungal spores: A critical review of the toxicological and epidemiological evidence as a basis for occupational exposure limit setting. Crit. Rev. Toxicol. 39: 799-864.
28. Edwards, S.W., and Preston, R. J. 2008. Systems biology and mode of action based risk assessment. Toxicol. Sci. 106: 312-318.
29. Egeghy, P. P., Judson, R., Gangwal, S., Mosher, S., Smith, D., Vail, J., and Cohen-Hubal, E. A. 2011. The exposure data landscape for manufactured chemicals. Sci. Total Environ. 414: 159-166.
30. Engel, A., and Lamm, S. H. 2008. Arsenic exposure and childhood cancer-A systematic review of the literature. J. Environ. Health 71: 12-16.
31. Furusawa, C., Suzuki, T., Kashiwagi, A., Yomo, T., and Kaneko, K, 2005. Ubiquity of lognormal distributions in intra-cellular reaction dynamic. Biophysics 1:25-40.
32. Gots, R. E., Layton, N. J., and Pirages, S. W. 2003. Indoor health: Background levels of fungi. J. Am. Ind. Hyg. Assoc. 64: 427-438.
33. Halloy, S., and Whigham, P. 2005. The lognormal as universal descriptor of unconstrained complex systems: A unifying theory for complexity. Complexity Int. 12: 1-12.
34. Hansen, A. M., Mathiesen, L., Pedersen, M., and Knudsen, L. E. 2008. Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies-A review. Int. J. Hyg. Environ. Health 211: 471-503.
35. Hoffmeyer, F., Raulf-Heimsoth, M., and Brüning, T. 2009. Exhaled breath condensate and airway inflammation. Curr. Opin. Allergy Clin. Immunol. 9:16-22.
36. Hubbard, H. F., Sobus, J. R., Pleil, J. D., Madden, M. C., and Tabucchi, S. 2009. Application of novel method to measure endogenous VOCs in exhaled breath condensate before and after exposure to diesel exhaust. J. Chromatogr. B 877: 3652-3658.
37. Hsueh, Y. M., Cheng, G. S.,Wu, M. M., Yu, H. S., Kuo, T. L., and Chen, C. J. 1995. Multiple risk-factors associated with arsenic-induced skin-cancer-Effects of chronic liver disease and malnutritional status. Br. J. Cancer 71: 109-114.
38. IARC. 2004. International Agency for Research on Cancer, Arsenic and arsenic compounds: Monograph 100C. http://monographs.iarc. fr/ENG/Monographs/vol100C/mono100C-6. pdf
39. Jomova, K., Jenisova, Z., Feszterova, M., Baros, S., Liska, J., Hudecova, D., Rhodes, C. J., and Valko, M. 2011. Arsenic: Toxicity, oxidative stress and human disease. J. Appl. Toxicol. 31: 95-107.
40. Jongeneelen, F. J. 2001. Benchmark guideline for urinary 1-hydroxypyrene as biomarker of occupational exposure to polycyclic aromatic hydrocarbons. Ann. Occup. Hyg. 4: 3-13.
41. Klatsky, A. L. 2006. Arsenic exposure and cardiovascular disease: A systematic review of the epidemiologic evidence. Am J Epidemiol 164: 194-195.
42. Labib, S., Yauk, C., Williams, A., Arlt, V. M., Phillips, D. H., White, P. A., and Halappanavar, S. 2012. Subchronic oral exposure to benzo(a)pyrene leads to distinct transcriptomic changes in the lungs that are related to carcinogenesis. Toxicol. Sci. 129: 213-224.
43. Larrick, J.W., andWright, S. C. 1990. Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J. 4: 3215-3223.
44. Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., and Seed, J. 2007. Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol. Sci. 99: 366-394.
45. Liao, D., Shaffer, M. L., He, F., Rodriguez-Colon, S., Wu, R., Whitzel, E., Bixler, E. O., and Cascio, W. E. 2011. Fine particulate air pollution is associated with higher vulnerability to atrial fibrillation-the APACR study. J. Toxicol. Environ. Health A 74: 693-705.
46. Limpert, E., Stahel, W. A., and Abbt, M. 2001. Lognormal distributions across the sciences: Keys and clues. Bioscience 51: 341-352.
47. Lin, Y. S., Kupper, L. L., and Rappaport, S. M. 2005. Air samples versus biomarkers for epidemiology. Occup. Environ. Med. 62: 750-760.
48. Lindstrom, A. B., and Pleil, J. D. 2002. A review of the USEPA's single breath canister (SBC) method for exhaled volatile organic biomarkers. Biomarkers 7: 189-208.
49. Lindstrom, A. B., Strynar, M. J., and Libelo, E. L. 2011. Polyfluorinated compounds: Past, present, and future. Environ. Sci. Technol. 45: 7954-7961.
50. Liu, S., and Pleil, J. D. 2001. Optimized determination of trace jet fuel VOCs in human blood using in-field liquid-liquid extraction with subsequent laboratory GC-MS analysis and on-column large volume injection. J. Chromatogr. B Biomed. Appl. 752: 159-171.
51. Maule, A. L., Heaton, K. J., Rodrigues, E., Smith, K. W., McLean, M. D., and Proctor, S. P. 2013. Postural sway and exposure to jet propulsion fuel 8 among US Air Force personnel. J. Occup. Environ. Med. 55: 446-453.
52. McLean, M. D., Rinehart, R. D., Ngo, L., Eisen, E. A., Kelsey, K. T., Wiencke, J. K., and Herrick, R. F. 2004. Urinary 1-hydroxypyrene and polycyclic aromatic hydrocarbon exposure among asphalt paving workers. Ann. Occup. Hyg. 48: 565-578.
53. McClenny, W. A., Daughtrey, E. H., Jr., Adams, J. R., Oliver, K. D., and Kronmiller, K. G. 1998. Volatile organic compound concentration patterns at the New Hendersonville monitoring site in the 1995 Southern Oxidant Study in the Nashville, Tennessee, area. J. Geophys. Res. Atmos. 103: 22509-22518.
54. McDougal, J. N., and Rogers, J. V. 2004. Local and systemic toxicity of JP-8 from cutaneous exposures. Toxicol. Lett. 149: 301-308.
55. McMichael, A. J. 1988, Carcinogenicity of benzene, toluene and xylene: Epidemiological and experimental evidence. IARC Sci Publ. 85: 3-18.
56. Meinardi S, Jin KB, Barletta B, Blake DR, and Vaziri ND, 2013. Exhaled breath and fecal volatile organic biomarkers of chronic kidney disease. Biochim Biophys Acta 1830: 2531-2537.
57. Meliker, J. R., and Nriagu, J. O. 2007. Arsenic in drinking water and bladder cancer: Review of epidemiological evidence. Trace Metals Contam. Environ. 9: 533-566.
58. Mink, P. J., Alexander, D. D., Barraj, L. M., Kelsh, M. A., and Tsuji, J. S. 2008. Lowlevel arsenic exposure in drinking water and bladder cancer: A review and meta-analysis. Regul. Toxicol. Pharmacol. 52: 299-310.
59. Nakayama, S., Strynar, M. J., Helfant, L., Egeghy, P. P., Ye, X., and Lindstrom, A. B. 2007. Perfluorinated Compounds in the Cape Fear Drainage Basin in North Carolina. Env Sci & Tech 41: 5271-5276.
60. National Institutes of Health. 2013. National Institutes of Health, National Children's Study. http://www.nichd.nih.gov/about/org/od/ncs/pages/index.aspx
61. National Research Council. 2007. Toxicity testing in the 21st century: A vision and a strategy. Washington, DC: National Academies Press.
62. National Research Council. 2012. Exposure science in the 21st century: A vision and a strategy. Washington, DC: National Academies Press.
63. Navas-Acien, A., Sharrett, A. R., and Guallar, E. 2006. Arsenic exposure and cardiovascular disease: A systematic review of the epidemiologic evidence. Am. J. Epidemiol. 164: 195-196.
64. North Carolina Department of Environment and Natural Resources. 2014. http://portal. ncdenr.org/web/guest/about-denr
65. North Carolina Department of Environment and Natural Resources. 2007. The North Carolina Department of Environment and Natural Resources
66. Division of Air Quality Ambient Air Monitoring Section: Public outreach for ambient air criteria monitoring in North Carolina. http://daq.state.nc.us/monitor/monitoring-overview-05082007.pdf
67. Ott, W. R. 1995 Environmental statistics and data analysis. Boca Raton, FL: CRC Press.
68. Perera, F. P., and Weinstein, I. B. 1982. Molecular epidemiology and carcinogen-DNA adduct detection: New approaches to studies of human cancer causation. J. Chron. Dis. 35: 581-600.
69. Perera, F. P. and Herbstman, J. 2011. Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol 31: 363-373.
70. Pleil, J. D. 2008. Role of exhaled breath biomarkers in environmental health science. J Toxicol Environ Health B 11: 613-626.
71. Pleil, J. D. 2009. Influence of systems biology response and environmental exposure level on between-subject variability in breath and blood biomarkers. Biomarkers 14: 560-571.
72. Pleil, J. D. 2012. Categorizing biomarkers of the human exposome and developing metrics for assessing environmental sustainability. J. Toxicol. Environ. Health B 15:264-280.
73. Pleil, J. D., and Sheldon, L. S. 2011. Adapting concepts from systems biology to develop systems exposure event networks for exposure science research. Biomarkers 16: 99-105.
74. Pleil, J. D., and Sobus, J. R. 2013. Estimating lifetime risk from spot biomarker data and intra-class correlation coefficients (ICC). J. Toxicol. Environ. Health A 76: 747-766.
75. Pleil, J. D., Smith, L. B., and Zelnick, S. D. 2000. Personal exposure to JP-8 jet fuel and exhaust at Air Force bases. Environ. Health Perspect. 108: 183-192.
76. Pleil, J. D., Vette, A. F., and Rappaport, S. M. 2004a. Assaying particle-bound polycyclic aromatic hydrocarbons from archived PM2.5 filters. J. Chromatogr. A 1033: 9-17.
77. Pleil, J. D., Vette, A. F., Johnson, B. A., and Rappaport, S. M. 2004b. Air levels of polycyclic aromatic hydrocarbons following the World Trade Center disaster. Proc. Natl. Acad. Sci. USA 101: 11685-11688.
78. Pleil, J. D., Hubbard, H. F., Sobus, J. R., and Madden, M. C. 2008. Volatile polar metabolites in exhaled breath condensate (EBC): Collection and analysis. J. Breath Res. 2: 026001.
79. Pleil, J. D., Stiegel, M. A., Sobus, J. R., Tabucchi, S., Ghio, A. J., and Madden, M. C. 2010. Cumulative exposure assessment for trace-level polycyclic aromatic hydrocarbons (PAHs) using human blood and plasma analysis. J. Chromatogr. B 878: 1753-1760.
80. Pleil, J. D., Stiegel, M. A., Sobus, J. R., Liu, Q., and Madden, M. C. 2011. Observing the human exposome as reflected in breath biomarkers: Heat map data interpretation for environmental and intelligence research. J. Breath Res. 5: 037104.
81. Pleil, J. D., Miekisch, W., Stiegel, M. A., and Beauchamp, J. D. 2014. Extending breath analysis to the cellular level: Current thoughts on the human microbiome and the expression of organic compounds in the human exposome. J. Breath Res. 8: 029001.
82. Rappaport, S. M. 1991. Assessment of longterm exposure to toxic substances in air. Ann. Occup. Hyg. 35: 61-121.
83. Rappaport, S. M., and Kupper, L. L. 2011. Quantitative exposure assessment. Raleigh, NC: LuLu Press.
84. Rappenglück, B. and Fabian, P. 1998. A study of BTEX-ratios in the urban area of Munich/Germany using rapid gas chromatography. Environ Sci & Pollut Res Int 5: 65-70.
85. Reiner, J. L., Strynar, M. J., Nakayama, S. F., Delinsky, A. D., Stanko, J. P., Fenton, S. E., and Lindstrom, A. B. 2009. Method development for the analysis of PFOA in gestationally exposed mice-Serum, urine, amniotic fluid, and whole pups. Reprod Toxicol 27: 423.
86. Risby, T. H., and Solga, S. F. 2006. Current status of clinical breath analysis. Appl. Phys. B 85: 421-426.
87. Ritchie, G., Still, K., Rossi, J., Bekkedal, M., Bobb, A., and Arfsten, D. 2003. Biological and health effects of exposure to kerosenebased jet fuels and performance additives. J. Toxicol. Environ. Health B 6: 357-451.
88. Sehnert, S. S., Jiang, L., Burdick, J. F., and Risby, T. H. 2002. Breath biomarkers for detection of human liver diseases: Preliminary study. Biomarkers 7: 174-187.
89. Singh A. K., Singh A., and Engelhardt, M. 1997. The lognormal distribution in environmental applications, EPA/600/S-97/006, U.S. Environmental Protection Agency, Las Vegas, NV. http://www.itrcweb.org/ism-1/references/Singh1997.pdf
90. Sobus, J. R., McClean, M. D., Herrick, R. F., Waidyanatha, S., Nylander-French, L. A., Kupper, L. L., and Rappaport, S. M. 2009a. Comparing urinary biomarkers of airborne and dermal exposure to polycyclic aromatic compounds in asphalt-exposed workers. Ann. Occup. Hyg. 53: 561-571.
91. Sobus, J. R., McClean, M. D., Herrick, R. F., Waidyanatha, S., Onyemauwa, F., Kupper, L. L., and Rappaport, S. M. 2009b. Investigation of PAH biomarkers in the urine of workers exposed to hot asphalt. Ann. Occup. Hyg. 53: 551-560.
92. Sobus, J. R., Pleil, J. D., McClean, M. D., Herrick, R. F., and Rappaport, S. M. 2010. Biomarker variance component estimation for exposure surrogate selection and toxicokinetic inference. Toxicol. Lett. 199: 247-253.
93. Sobus, J. R., Tan, Y. M., Pleil, J. D., and Sheldon, L. S. 2011. A biomonitoring framework to support exposure and risk assessments. Sci. Total Environ. 409: 4875-884.
94. Steenland, K., Fletcher, T., and Savitz, D. A. 2010. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ. Health Perspect. 118: 1100-1108.
95. Stiegel, M. A. 2008. A comparison of indoor fungal spore concentrations between naturally ventilated and mechanically ventilated dormitories at Duke University. Technical report for master of science in public health, University of North Carolina at Chapel Hill.
96. Straus, D. C. 2011. The possible role of fungal contamination in sick building syndrome. Front. Biosci. 3: 562-580.
97. Strom D. J. and Stansbury P. S. 2000. Determining Parameters of Lognormal Distributions from Minimal Information. AIHAJ-American Industrial Hygiene Association 61: 877-880.
98. Strynar, M. J., Lindstrom, A. B., Nakayama, S. F., Egeghy, P. P., and Helfant, L. 2012. Application of a method for the analysis of perfluorinated compounds in surface soils. Chemosphere 86: 252-257.
99. Strynar, M. J., and Lindstrom, A. B. 2008. Perfluorinated compounds in house dust from Ohio and North Carolina, USA. Environ. Sci. Technol. 42: 3751-3756.
100. Symanski, E., Stock, T. H., Tee, P. G., and Chan, W. 2009. Demographic, residential, and behavioral determinants of elevated exposures to benzene, toluene, ethylbenzene, and xylenes among the U.S. population: Results from 1999-2000 NHANES. J. Toxicol. Environ. Health A 72: 915-924.
101. Tan, Y. M., Sobus, J. R., Chang, D., Goldsmith, M., Tornero-Velez, R., Pleil, J. D., and Dary, C. C. 2012. Reconstructing human exposures using biomarkers of exposure and other clues. J. Toxicol. Environ. Health B 15: 22-38.
102. Tsai, S.-S., and Yang, C.-Y. 2014. Fine particulate air pollution and hospital admissions for pneumonia in a subtropical city: Taipei, Taiwan. J. Toxicol. Environ. Health A 77: 192-201.
103. Tu, R. H., Mitchell, C. S., Kay, G. G., and Risby, T. H. 2004. Human exposure to the jet fuel, JP-8. Aviat. Space Environ. Med. 75: 49-59.
104. Umber, B. J., Shin, H. W., Meinardi, S., Leu, S. Y., Zaldivar, F., Cooper, D. M., and Blake, D. R. 2013. Gas signatures from Escherichia coli and Escherichia coli-inoculated human whole blood. Clin. Translational Med. 2: 13.
105. U.S. Environmental Protection Agency. 2013. U.S. Environmental Protection Agency, Technology Transfer Network, PM2.5 policy and guidance. http://www.epa.gov/ttnamti1/pmpolgud.html
106. U.S. Environmental Protection Agency. 2013. U.S. Environmental Protection Agency, Technology Transfer Network, Polycyclic organic matter (POM). http://www.epa.gov/ttn/atw/hlthef/polycycl.html
107. Vinken, M. 2013. The adverse outcome pathway: A pragmatic tool in toxicology. Toxicology 312: 158-165.
108. Wislocki, P. G., Wood, A. W., Chang, R. L., Levin, W., Yagi, H., Hernandez, O., Jerina, D. M., and Conney, A. H. 1976. High mutagenicity and toxicity of a diol epoxide derived from benzo[a]pyrene. Biochem. Biophys. Res. Commun. 68: 1006-1012.
109. Zhu, J., Bean, H. D., Wargo, M. J., Leclair, L. W., and Hill, J. E. 2013. Detecting bacterial lung infections: In vivo evaluation of in vitro volatile fingerprints J. Breath Res. 7: 016003.